Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.

Reale M, Iarlori C, Gambi F, Feliciani C, Salone A, Toma L, DeLuca G, Salvatore M, Conti P, Gambi D.

J Neuroimmunol. 2004 Mar;148(1-2):162-71.

PMID:
14975597
2.

The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.

Reale M, Iarlori C, Gambi F, Feliciani C, Isabella L, Gambi D.

Neuropharmacology. 2006 Apr;50(5):606-13. Epub 2006 Jan 30.

PMID:
16445950
3.

Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients.

Reale M, Iarlori C, Gambi F, Lucci I, Salvatore M, Gambi D.

Exp Gerontol. 2005 Mar;40(3):165-71. Epub 2005 Jan 8.

PMID:
15763393
4.

Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells.

Gambi F, Reale M, Iarlori C, Salone A, Toma L, Paladini C, De Luca G, Feliciani C, Salvatore M, Salerno RM, Theoharides TC, Conti P, Exton M, Gambi D.

J Clin Psychopharmacol. 2004 Jun;24(3):314-21.

PMID:
15118486
5.

Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease.

Iarlori C, Gambi D, Gambi F, Lucci I, Feliciani C, Salvatore M, Reale M.

Exp Gerontol. 2005 Jul;40(7):605-11.

PMID:
15935590
6.

Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.

Reale M, Iarlori C, Feliciani C, Gambi D.

J Alzheimers Dis. 2008 Jun;14(2):147-59.

PMID:
18560127
7.

The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.

Federico A, Tuccillo C, Grossi E, Abbiati R, Garbagna N, Romano M, Tiso A, Blanco Cdel V, Loguercio C.

Eur Rev Med Pharmacol Sci. 2009 Jul-Aug;13(4):285-93.

PMID:
19694343
8.

Peripheral cytokines profile in Parkinson's disease.

Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, Onofrj M.

Brain Behav Immun. 2009 Jan;23(1):55-63. doi: 10.1016/j.bbi.2008.07.003. Epub 2008 Jul 17.

PMID:
18678243
9.
10.

Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production.

Pellicanò M, Bulati M, Buffa S, Barbagallo M, Di Prima A, Misiano G, Picone P, Di Carlo M, Nuzzo D, Candore G, Vasto S, Lio D, Caruso C, Colonna-Romano G.

J Alzheimers Dis. 2010;21(1):181-92. doi: 10.3233/JAD-2010-091714.

PMID:
20413861
11.

Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.

Sørensen LK, Havemose-Poulsen A, Bendtzen K, Holmstrup P.

J Periodontol. 2009 Feb;80(2):282-9. doi: 10.1902/jop.2009.080347 .

PMID:
19186969
12.

Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.

Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L.

Eur J Neurosci. 2006 May;23(10):2648-56.

PMID:
16817867
13.

IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors.

Lugaresi A, Di Iorio A, Iarlori C, Reale M, De Luca G, Sparvieri E, Michetti A, Conti P, Gambi D, Abate G, Paganelli R.

Exp Gerontol. 2004 Apr;39(4):653-7.

PMID:
15050302
14.

Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.

Nizri E, Hamra-Amitay Y, Sicsic C, Lavon I, Brenner T.

Neuropharmacology. 2006 Apr;50(5):540-7. Epub 2005 Dec 5.

PMID:
16336980
15.

Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria.

Dos Santos JC, Azor MH, Nojima VY, Lourenço FD, Prearo E, Maruta CW, Rivitti EA, da Silva Duarte AJ, Sato MN.

Int Immunopharmacol. 2008 Oct;8(10):1433-40. doi: 10.1016/j.intimp.2008.05.016. Epub 2008 Jun 27.

PMID:
18586117
16.

Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells.

Weber TE, Kerr BJ.

Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):139-47. Epub 2006 May 24.

PMID:
16725211
17.
18.

Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.

Reale M, Di Nicola M, Velluto L, D'Angelo C, Costantini E, Lahiri DK, Kamal MA, Yu QS, Greig NH.

Curr Alzheimer Res. 2014;11(6):608-22.

PMID:
24359497
20.

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.

Raddatz D, Bockemühl M, Ramadori G.

Eur J Gastroenterol Hepatol. 2005 May;17(5):547-57.

PMID:
15827446

Supplemental Content

Support Center